All terms in GO
| Label | Id | Description |
|---|---|---|
| reelin-mediated signaling pathway | GO_0038026 |
The series of molecular signals initiated by the binding of reelin (a secreted glycoprotein) to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
|
| apolipoprotein A-I-mediated signaling pathway | GO_0038027 |
The series of molecular signals initiated by apolipoprotein A-I binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
|
| insulin receptor signaling pathway via phosphatidylinositol 3-kinase | GO_0038028 |
An insulin receptor signaling pathway in which the signal is transmitted via the phosphatidylinositol 3-kinase cascade.
|
| insulin receptor signaling pathway | GO_0008286 |
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
| epidermal growth factor receptor signaling pathway via MAPK cascade | GO_0038029 |
An epidermal growth factor receptor signaling pathway in which the signal is transmitted via the MAPKKK cascade.
|
| G protein-coupled olfactory receptor activity | GO_0038022 |
Combining with an odorant and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
|
| reelin receptor activity | GO_0038025 |
Combining with the secreted glycoprotein reelin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
| response to fluoxetine | GO_0014076 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluoxetine stimulus. Fluoxetine increases the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor.
|
| response to antidepressant | GO_0036276 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antidepressant stimulus, a mood-stimulating drug.
|
| response to tropane | GO_0014073 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tropane stimulus. Tropane is a nitrogenous bicyclic organic compound mainly known for a group of alkaloids derived from it (called tropane alkaloids), which include, among others, atropine and cocaine.
|
| insulin receptor recycling | GO_0038020 |
The process that results in the return of an insulin receptor to an active state at the plasma membrane. An active state is when the receptor is ready to receive an insulin signal. Internalized insulin receptors can be recycled to the plasma membrane or sorted to lysosomes for protein degradation.
|
| receptor recycling | GO_0001881 |
The process that results in the return of receptor molecules to an active state and an active cellular location after they have been stimulated by a ligand. An active state is when the receptor is ready to receive a signal.
|
| response to cycloalkane | GO_0014071 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloalkane stimulus. A cycloalkane is a cyclic saturated hydrocarbon having the general formula CnH2n.
|
| leptin receptor activity | GO_0038021 |
Combining with the fat-cell specific hormone leptin and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
| response to isoquinoline alkaloid | GO_0014072 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an isoquinoline alkaloid stimulus. An isoquinoline alkaloid is any member of a group of compounds with the heterocyclic ring structure of benzo(c)pyridine which is a structure characteristic of the group of opium alkaloids.
|
| IKKalpha-IKKalpha complex | GO_0038059 |
A homodimeric protein complex containing two IkappaB kinase (IKK) alpha subunits.
|
| BMP secretion | GO_0038055 |
The controlled release of a member of the BMP family of proteins from a cell.
|
| negative regulation of BMP signaling pathway by negative regulation of BMP secretion | GO_0038056 |
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway by stopping, preventing or reducing the frequency, rate or extent of secretion of a member of the BMP family of proteins from the signaling cell.
|
| negative regulation of BMP secretion | GO_2001285 |
Any process that stops, prevents or reduces the frequency, rate or extent of BMP secretion.
|
| negative regulation of BMP signaling pathway | GO_0030514 |
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|